Search
Search Results
##search.searchResults.foundPlural##
-
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3323PDF: 1388HTML: 4156 -
THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS
2852PDF: 1112HTML: 1960 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1589PDF: 935HTML: 386 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4875PDF: 1606HTML: 2268Untitled: 254Untitled: 268Untitled: 288Untitled: 238Untitled: 255 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
818PDF: 588HTML: 285 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2090PDF: 1639HTML: 804 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
2488PDF: 911HTML: 7996Untitled: 215 -
QUALITY OF LIFE IN PATIENTS WITH THALASSEMIA MAJOR AND INTERMEDIA IN KERMAN-IRAN (I.R.)
1745PDF: 808HTML: 2395Cover Letter: 212 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1423PDF: 487HTML: 18625Figure 1: 187Figure 2: 167Figure 3: 185Figure 4: 220Figure 5: 198 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2146PDF: 1091HTML: 15737COVER LETTER: 214 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3802PDF: 939HTML: 6879 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1506PDF: 1475PDF: 1051HTML: 232 -
COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis
924PDF: 1285HTML: 149 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1530PDF: 1104HTML: 439Suppl. Figure: 204Suppl. Tables: 225 -
Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19
3278PDF: 1915HTML: 992 -
Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP
2316PDF: 824HTML: 903Figure 2: 235Figure 1: 193 -







